IBO Tambahing bathi saben saham ing taun lumaku impactbiomedinc.com
Impact BioMedical Inc (IBO) develops medical assets through licensing alliances and joint commercialization. The percentage deviation of EPS from the previous year's level clearly demonstrates the dynamics of this process, where the 0.00 metric determines this level. The fundamentals are based on R&D of universal antiviral agents with high scalability potential, although current cash flow relies on support from the parent structure due to the pre-commercial status of the developments.
Rincian metrik keuangan lan pasar Impact BioMedical Inc (IBO)
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban utang lan likuiditas:
Utang Agregat marang Ekuitas Impact BioMedical Inc|IBO - Utang jangka dawa marang modal|Utang jangka cendhak marang modal impactbiomedinc.com|IBO - Gunggung utang perusahaan|Utang marang nilai buku Impact BioMedical Inc|IBO - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Impact BioMedical|Rasio jangkoan perantara impactbiomedinc.com
- data bathi lan kelipatan valuasi:
IBO - Bathi resik|Bathi sing dikarepake Impact BioMedical Inc|IBO - Pangali P/E|Kapitalisasi marang proyeksi bathi Impact BioMedical, Inc.|IBO - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Impact BioMedical Inc|IBO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Impact BioMedical|IBO - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan impactbiomedinc.com|IBO - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Impact BioMedical Inc
Pambiji fundamental:IBO, Impact BioMedical, Inc.
This indicator measures the year-over-year dynamics of net earnings per share, reflecting the actual efficiency of capital generation. By analyzing the percentage change in earnings per share compared to the previous year, an investor assesses the business model's resilience to market shocks and operating expenses. For Impact BioMedical Inc (IBO), this growth confirms the successful integration of sustainable R&D protocols and resource optimization, which reduce overall operating expenses.
Pesaing wigati
Kacepetan wutah bathi saben saham ing taun lumaku Haleon PLC (HLN)|Wutah bathi saben saham ing taun lumaku Kenvue Corp|VRNA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku MENS|Prakiraan wutah bathi resik saben saham ing taun iki ligand.com|Wutah bathi saben saham ing taun lumaku Amneal AMRX|PRGO - Wutah bathi resik saben saham ing taun iki|ALVO - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku LQDA|GLPG: Wutah bathi ing taun lumaku|anipharmaceuticals.com (ANIP) - Wutah bathi ing taun lumaku|MNKD (MannKind) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Amphastar Pharmaceuticals Inc (AMPH)|Wutah bathi resik saben saham ing taun iki PCRX (Pacira)|Wutah bathi resik saben siji saham kanggo taun lumaku SPRY|Theravance Biopharma - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku AQST|scPharma - Wutah bathi ing taun lumaku|TECX: Wutah bathi saben saham ing taun lumaku|TNXP: Wutah bathi ing taun lumaku|SXTC - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Eupraxia Pharmaceuticals, Inc.|Kacepetan wutah bathi saben saham ing taun lumaku bioharvest.com BHST|Wutah bathi saben saham ing taun lumaku eXoZymes (EXOZ)|Wutah bathi resik saben saham ing taun iki oramed.com ORMP|Wutah bathi ing taun lumaku ENTX (Entera Bio)|MindWalk Therapeutics (HYFT) - Kacepetan wutah bathi saben saham ing taun lumaku|ABVC BioPharma - Wutah bathi ing taun lumaku|CPIX (cumberlandpharma.com) - Wutah bathi saben saham ing taun iki|QNTM: Wutah bathi ing taun lumaku|FGEN - Prakiraan wutah bathi resik saben saham ing taun iki|TELO (Telomir Pharma) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Rani Therapeutics Inc (RANI)|Wutah bathi ing taun lumaku SNYR|Wutah bathi ing taun lumaku rallybio.com (RLYB)|Wutah bathi saben saham ing taun lumaku Lexaria Bioscience Corp. LEXX|Pulmatrix Inc - Wutah bathi saben saham ing taun lumaku|PTHL: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku APM (Aptorum Group Limited)|LYRA: Wutah bathi ing taun lumaku|TNFA - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku cbdMD Inc.|Wutah bathi saben saham ing taun iki PRFX (PainReform Ltd)|Wutah bathi ing taun lumaku CYTO|Wutah bathi resik saben saham ing taun iki Lipella Pharma LIPO|Wutah bathi ing taun lumaku OPTN (OptiNose, Inc.)|Prakiraan wutah bathi resik saben saham ing taun iki pieris.com (PIRS)|Procaps - Wutah bathi ing taun lumaku|PTPI: Wutah bathi saben saham ing taun lumaku|Qilian International Holding Group Limited (QLI) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku ACELYRIN Inc. (SLRN)|Wutah bathi saben saham ing taun lumaku TFF Pharmaceuticals
